These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Retrospective Diagnosis of Parkinsonian Syndromes Using Whole-Brain Atrophy Rates. Guevara C; Bulatova K; Soruco W; Gonzalez G; FarÃas GA Front Aging Neurosci; 2017; 9():99. PubMed ID: 28469572 [No Abstract] [Full Text] [Related]
3. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy. Kim KJ; Jeong SJ; Kim JM Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC Brain; 2006 Apr; 129(Pt 4):1040-9. PubMed ID: 16455792 [TBL] [Abstract][Full Text] [Related]
5. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Eckert T; Sailer M; Kaufmann J; Schrader C; Peschel T; Bodammer N; Heinze HJ; Schoenfeld MA Neuroimage; 2004 Jan; 21(1):229-35. PubMed ID: 14741660 [TBL] [Abstract][Full Text] [Related]
7. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. Juh R; Kim J; Moon D; Choe B; Suh T Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329 [TBL] [Abstract][Full Text] [Related]
8. MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects. Paviour DC; Price SL; Lees AJ; Fox NC J Neurol; 2007 Apr; 254(4):478-81. PubMed ID: 17401522 [TBL] [Abstract][Full Text] [Related]
9. PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes. Raffel DM; Koeppe RA; Little R; Wang CN; Liu S; Junck L; Heumann M; Gilman S J Nucl Med; 2006 Nov; 47(11):1769-77. PubMed ID: 17079809 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879 [TBL] [Abstract][Full Text] [Related]
11. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy]. Yoshita M; Hayashi M; Hirai S Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes. Federico F; Simone IL; Lucivero V; Mezzapesa DM; de Mari M; Lamberti P; Petruzzellis M; Ferrari E Ital J Neurol Sci; 1999 Aug; 20(4):223-9. PubMed ID: 10551908 [TBL] [Abstract][Full Text] [Related]
14. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy. Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321 [TBL] [Abstract][Full Text] [Related]
15. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging. Tsukamoto K; Matsusue E; Kanasaki Y; Kakite S; Fujii S; Kaminou T; Ogawa T Neuroradiology; 2012 Sep; 54(9):947-55. PubMed ID: 22274571 [TBL] [Abstract][Full Text] [Related]
17. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy. Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485 [TBL] [Abstract][Full Text] [Related]
18. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Reimann M; Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schoels L; Reichmann H; Berg D; Ziemssen T J Neural Transm (Vienna); 2010 Jan; 117(1):69-76. PubMed ID: 19763772 [TBL] [Abstract][Full Text] [Related]
20. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia. Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]